-
Never place tissue in formalin or
other preservatives.
-
Do not collect tissue using
heparin.
-
Do not place any tissue in
heparinized containers, or tubes with heparin solution
-
Do not use heparin when collecting
CT- or ultrasound-guided aspirates, core biopsies, FNA specimens
or bone marrow.
-
Do not put core biopsies in OCT
-
Tissue blocks cannot be used to
manufacture vaccine.
-
Except for peripheral blood, all
specimens should be kept cold (either on 'wet' or dry ice) to
prevent RNA degradation.
-
If transporting a specimen on 'wet'
ice, cover fresh tissue with normal saline to reduce RNA
degradation.
-
Freshly excised lymph nodes (LN)
are the preferred tissue. Tissue should be immediately
placed in an appropriate container (tight screw top) of normal
saline and shipped on 'wet' ice.
-
Amount of LN tissue required to
manufacture vaccine:
-
minimum dimension of ~ 0.3 cm
-
2-3 smaller specimens are
better than one large sample, but avoid creating 'diced'
specimens.
-
Excisional lymph nodes should
be less than or equal to 1.0 gram.
-
Collect core biopsies using an 1-14
gauge needle to yield a core biopsy ~0.2 cm in diameter by at
least 1 cm in length.
-
Core biopsy snap freezing must
occur immediately to freeze the tissue solid to prevent RNA
degradation.
-
Immediately place in a
container and placing on dry ice until frozen solid (~ 10
minutes), or
-
Immediately place in liquid
nitrogen for ~ 20 seconds or, in ultra low temperature freezer
(-80 C) for ~ 10 minutes.
-
Fine Needle aspirates:
-
provide 2-3 aspirates (.1 - .2
cc each) in separate containers.
-
number aspirates in order of
collection.
-
bloody aspirates are unlikely
to yield adequate RNA.
-
Bone marrow and other core
biopsies
-
Peripheral blood must display an
absolute lymphocyte count of 5 x 106 cells/mL by manual
differential. 7-10 mL of blood is needed, collected in EDTA tubes
(purple tops).